Who owns the CLINICAL RESEARCH FOR ALL trademark?

The CLINICAL RESEARCH FOR ALL trademark is owned by Alcanza Clinical Research, LLC.

What class is the CLINICAL RESEARCH FOR ALL trademark registered in?

The CLINICAL RESEARCH FOR ALL trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for CLINICAL RESEARCH FOR ALL?

The USPTO serial number for CLINICAL RESEARCH FOR ALL is 97353259.

What is the registration number for CLINICAL RESEARCH FOR ALL?

CLINICAL RESEARCH FOR ALL is registered under USPTO registration number 7305997.

CLI

USPTO Trademark Record

REGISTERED

CLINICAL RESEARCH FOR ALL

SN 97353259·Reg 7305997·Filed Apr 08, 2022

Owner Alcanza Clinical Research, LLC

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

CLINICAL RESEARCH FOR ALL (Serial No. 97353259), Registration No. 7305997, is a registered US trademark filed on Apr 08, 2022 by Alcanza Clinical Research, LLC. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: February 13, 2030

Mark Intelligence

CLINICAL RESEARCH FOR ALL (Reg. #7305997) is a registered US trademark that has been protecting its owner, Alcanza Clinical Research, LLC, since 2022. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 08, 2022

SERIAL

97353259

REG#

7305997

REGISTERED

Feb 13, 2024

Owner

Applicant

Alcanza Clinical Research, LLC

Entity

LLC

State

Address

615 Crescent Executive Court, Suite 120, Lake Mary, FL, 32746

Country

Attorney

NameMark A. Wright

Law firm

Mark A. Wright MCLANE MIDDLETON, PROFESSIONAL ASSOCIATION

Docket

122938

Address

900 ELM STREET, P.O. BOX 326, MANCHESTER, NH 03105-0326, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateApr 08, 2022

Serial Number97353259

Registration No.7305997

Registration DateFeb 13, 2024

Status DateFeb 13, 2024

Published for OppositionApr 11, 2023

Mark TypeStandard characters

Attorney Docket122938

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jun 30, 2022

First use in commerce: Jun 30, 2022

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

26 events

REGISTERED-PRINCIPAL REGISTER

Feb 13, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 13, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 12, 2024

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 11, 2024

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 15, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 1 GRANTED

Dec 14, 2023

SOU EXTENSION 1 GRANTED

STATEMENT OF USE PROCESSING COMPLETE

Dec 14, 2023

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 13, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

USE AMENDMENT FILED

Dec 05, 2023

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Dec 05, 2023

TEAS STATEMENT OF USE RECEIVED

SOU TEAS EXTENSION RECEIVED

Dec 05, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Dec 05, 2023

SOU EXTENSION 1 FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 06, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 11, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Apr 11, 2023

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 22, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 08, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 07, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 07, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 07, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO EXAMINER

Jan 26, 2023

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Jan 26, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jan 26, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 26, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION ENTERED

Apr 12, 2022

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 12, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

CLINICAL RESEARCH FOR ALL

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Alcanza Clinical Research, LLC

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Mark A. Wright

Resources

Company